- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 215/16 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
Patent holdings for IPC class C07D 215/16
Total number of patents in this class: 86
10-year publication summary
|
4
|
7
|
10
|
3
|
3
|
4
|
6
|
4
|
2
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Merck Sharp & Dohme Corp. | 2198 |
3 |
| Boehringer Ingelheim International GmbH | 4665 |
3 |
| The Johns Hopkins University | 5662 |
3 |
| Agc, Inc. | 4820 |
3 |
| The Regents of the University of California | 19887 |
2 |
| Massachusetts Institute of Technology | 10041 |
2 |
| Astellas Pharma Inc. | 1086 |
2 |
| Chemagis Ltd. | 33 |
2 |
| Hetero Research Foundation | 173 |
2 |
| Flagship Pioneering Innovations V, Inc. | 222 |
2 |
| Ancureall Pharmaceutical (Shanghai) Co., Ltd. | 11 |
2 |
| Janssen Pharmaceutica N.V. | 3392 |
1 |
| Wyeth LLC | 652 |
1 |
| Syngenta Participations AG | 1906 |
1 |
| Bayer AG | 3332 |
1 |
| The Regents of the University of Michigan | 4689 |
1 |
| The Trustees of Columbia University in the City of New York | 3565 |
1 |
| President and Fellows of Harvard College | 5972 |
1 |
| Abbvie Inc. | 1805 |
1 |
| Vertex Pharmaceuticals (europe) Limited | 17 |
1 |
| Other owners | 51 |